Population Pharmacokinetics and Exposure-Response Analyses from Phase I-III Studies Support Copanlisib Dose Selection in Relapsed Indolent Non-Hodgkin Lymphoma
| Autor: | Moss, Jonathan *, Garmann, Dirk *, Austin, Rupert *, Hiemeyer, Florian *, Matasar, Matthew J., Zinzani, Pier Luigi, Beckert, Vita *, Mongay Soler, Lidia *, Childs, Barrett H., Morcos, Peter N. * |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3629-3631 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|